{"id":1019406,"date":"2026-11-10T09:07:53","date_gmt":"2026-11-10T14:07:53","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2\/"},"modified":"2026-11-10T09:07:53","modified_gmt":"2026-11-10T14:07:53","slug":"liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2\/","title":{"rendered":"Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference"},"content":{"rendered":"
\n

MORRISVILLE, N.C., Nov. 10, 2026 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) today announced that Dr. Roger Jeffs, Chief Executive Officer, and Michael Kaseta, Chief Operating Officer and Chief Financial Officer, will provide an update on the company\u2019s business in a fireside chat at the 2026 Jefferies Global Healthcare Conference,<\/strong>Tuesday, November 17, at 10 a.m. ET\/3 p.m. BT <\/strong>in London.<\/p>\n

Access to these events will be available on the \u201cInvestors\u201d page of Liquidia\u2019s website at https:\/\/liquidia.com\/investors\/events-and-presentations<\/a>. A replay of the webcast will be archived on the Company’s website for at least 30 days.<\/p>\n

\n About Liquidia Corporation<\/strong>\n <\/p>\n

Liquidia Corporation is a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases. The company\u2019s current focus spans the development and commercialization of products in pulmonary hypertension and other applications of its proprietary PRINT\u00ae<\/sup> Technology. PRINT enabled the creation of YUTREPIA\u00ae<\/sup> (treprostinil) inhalation powder, approved for the treatment of pulmonary arterial hypertension (PAH), and in development for Raynaud\u2019s phenomenon secondary to systemic sclerosis (SSc-RP). The company is also developing L606, an investigational extended-release formulation of treprostinil administered twice daily via a next-generation nebulizer to treat PAH and pulmonary hypertension associated with interstitial lung disease (PH-ILD). To learn more about Liquidia, please visit www.liquidia.com<\/a>.<\/p>\n

\n Contact Information<\/strong>
\n
\n Investors:<\/strong>
\n
Jason Adair
Chief Business Officer
919.328.4350
Jason.adair@liquidia.com<\/a><\/p>\n

\n Media:<\/strong>
\n
\n media@liquidia.com<\/a>\n <\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

MORRISVILLE, N.C., Nov. 10, 2026 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) today announced that Dr. Roger Jeffs, Chief Executive Officer, and Michael Kaseta, Chief Operating Officer and Chief Financial Officer, will provide an update on the company\u2019s business in a fireside chat at the 2026 Jefferies Global Healthcare Conference,Tuesday, November 17, at 10 a.m. ET\/3 p.m. BT in London. Access to these events will be available on the \u201cInvestors\u201d page of Liquidia\u2019s website at https:\/\/liquidia.com\/investors\/events-and-presentations. A replay of the webcast will be archived on the Company’s website for at least 30 days. About Liquidia Corporation Liquidia Corporation is a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases. The company\u2019s … <\/p>\n

Continue reading “Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1019406","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nLiquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MORRISVILLE, N.C., Nov. 10, 2026 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) today announced that Dr. Roger Jeffs, Chief Executive Officer, and Michael Kaseta, Chief Operating Officer and Chief Financial Officer, will provide an update on the company\u2019s business in a fireside chat at the 2026 Jefferies Global Healthcare Conference,Tuesday, November 17, at 10 a.m. ET\/3 p.m. BT in London. Access to these events will be available on the \u201cInvestors\u201d page of Liquidia\u2019s website at https:\/\/liquidia.com\/investors\/events-and-presentations. A replay of the webcast will be archived on the Company’s website for at least 30 days. About Liquidia Corporation Liquidia Corporation is a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases. The company\u2019s … Continue reading "Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-10T14:07:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3Mzg1NiM3OTU1ODcyIzIwODQ0NjA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference\",\"datePublished\":\"2026-11-10T14:07:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2\\\/\"},\"wordCount\":241,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3Mzg1NiM3OTU1ODcyIzIwODQ0NjA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2\\\/\",\"name\":\"Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3Mzg1NiM3OTU1ODcyIzIwODQ0NjA=\",\"datePublished\":\"2026-11-10T14:07:53+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3Mzg1NiM3OTU1ODcyIzIwODQ0NjA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3Mzg1NiM3OTU1ODcyIzIwODQ0NjA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2\/","og_locale":"en_US","og_type":"article","og_title":"Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference - Market Newsdesk","og_description":"MORRISVILLE, N.C., Nov. 10, 2026 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) today announced that Dr. Roger Jeffs, Chief Executive Officer, and Michael Kaseta, Chief Operating Officer and Chief Financial Officer, will provide an update on the company\u2019s business in a fireside chat at the 2026 Jefferies Global Healthcare Conference,Tuesday, November 17, at 10 a.m. ET\/3 p.m. BT in London. Access to these events will be available on the \u201cInvestors\u201d page of Liquidia\u2019s website at https:\/\/liquidia.com\/investors\/events-and-presentations. A replay of the webcast will be archived on the Company’s website for at least 30 days. About Liquidia Corporation Liquidia Corporation is a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases. The company\u2019s … Continue reading \"Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-10T14:07:53+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3Mzg1NiM3OTU1ODcyIzIwODQ0NjA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference","datePublished":"2026-11-10T14:07:53+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2\/"},"wordCount":241,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3Mzg1NiM3OTU1ODcyIzIwODQ0NjA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2\/","name":"Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3Mzg1NiM3OTU1ODcyIzIwODQ0NjA=","datePublished":"2026-11-10T14:07:53+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3Mzg1NiM3OTU1ODcyIzIwODQ0NjA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3Mzg1NiM3OTU1ODcyIzIwODQ0NjA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/liquidia-corporation-to-present-at-2026-jefferies-global-healthcare-conference-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1019406","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1019406"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1019406\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1019406"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1019406"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1019406"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}